Literature DB >> 2320723

The relationship between radiosensitivity and repair of potentially lethal damage in human tumor cell lines with implications for radioresponsiveness.

P J Deschavanne1, B Fertil, N Chavaudra, E P Malaise.   

Abstract

The relationship between intrinsic radiosensitivity and repair capacity was studied for 22 human tumor cell lines in vitro. The experimental material was taken from 19 published papers. Parameters from three radiobiological models were used to assess this relationship: the one-hit multitarget model (D0 and n), the linear-quadratic model (alpha and beta), and the mean inactivation dose (D). Data were obtained for cells in three stages: exponentially growing cells (exp), plateau-phase cells plated immediately after irradiation (ip), and plateau-phase cells plated after completion of PLD repair (dp). No significant difference was found between radiosensitivity of exp and ip cells. There was no correlation between repair capacity and intrinsic radiosensitivity assessed with plateau-phase cells plated immediately after irradiation. The correlation studies between intrinsic radiosensitivity or repair capacity and clinical responsiveness were achieved by assigning cell lines to one of three groups of decreasing in vivo radioresponsiveness: highly, medium, and poorly responsive. There was a significant correlation between radiosensitivity and radioresponsiveness, but no correlation between repair capacity and radioresponsiveness. The average repair capacity was about 0.6 Gy, in terms of D. Three parameters, the mean inactivation dose of exponentially growing cells, of plateau-phase cells plated immediately after irradiation, and of plateau-phase cells plated after completion of PLD repair, could be used equally to assess the relationship between in vitro data and radioresponsiveness. The present results are compared to those obtained in a similar study on a group of 48 nontransformed fibroblast cell strains.

Entities:  

Mesh:

Year:  1990        PMID: 2320723

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  6 in total

1.  Induction and characterization of human glioma clones with different radiosensitivities.

Authors:  J Wang; L Hu; N Gupta; T Shamseldin; T Ozawa; J Klem; M Cardell; D F Deen
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

2.  The proteasome inhibitor MG-132 protects hypoxic SiHa cervical carcinoma cells after cyclic hypoxia/reoxygenation from ionizing radiation.

Authors:  Frank Pajonk; Thorsten Grumann; William H McBride
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

3.  Effects of radiation fractionation on four squamous cell carcinoma lines with dissimilar inherent radiation sensitivity.

Authors:  K Pekkola-Heino; J Kulmala; P Klemi; T Lakkala; K Aitasalo; H Joensuu; R Grenman
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

4.  Evaluation of the dosimetric and radiobiological parameters in four radiotherapy regimens for synchronous bilateral breast cancer.

Authors:  Sang-Won Kang; Seonghee Kang; Boram Lee; Changhoon Song; Keun-Yong Eom; Bum-Sup Jang; In Ah Kim; Jae-Sung Kim; Woong Cho; Dong-Suk Shin; Jin-Young Kim; Jin-Beom Chung
Journal:  J Appl Clin Med Phys       Date:  2022-06-21       Impact factor: 2.243

5.  Simultaneous integrated boost radiotherapy for bilateral breast: a treatment planning and dosimetric comparison for volumetric modulated arc and fixed field intensity modulated therapy.

Authors:  Giorgia Nicolini; Alessandro Clivio; Antonella Fogliata; Eugenio Vanetti; Luca Cozzi
Journal:  Radiat Oncol       Date:  2009-07-24       Impact factor: 3.481

6.  An Estimation of Radiobiological Parameters for Head-and-Neck Cancer Cells and the Clinical Implications.

Authors:  X Sharon Qi; Qiuhui Yang; Steve P Lee; X Allen Li; Dian Wang
Journal:  Cancers (Basel)       Date:  2012-06-15       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.